Literature DB >> 8912143

Expression ratio of hepatocyte nuclear factor-1 to variant hepatocyte nuclear factor-1 in differentiation of hepatocellular carcinoma and hepatoblastoma.

T Ninomiya1, Y Hayashi, K Saijoh, K Ohta, S Yoon, H Nakabayashi, T Tamaoki, M Kasuga, H Itoh.   

Abstract

BACKGROUND/AIMS: Liver-specific protein genes have multiple cis-/trans-acting elements, but those accountable for hepatocytic differentiation are unclear. An AT-rich core sequence (AT motif) is essential as a cis-acting element for the hepatic transcription. Homologous proteins hepatocyte nuclear factor-1 (HNF-1) and variant HNF-1 (vHNF-1) bind to this motif. The ratio of HNF-1 to vHNF-1 mRNA was examined in various liver tissues with respect to their differentiation.
METHODS: The competitive reverse transcriptional polymerase chain reaction was employed to amplify HNF-1 and vHNF-1 mRNA simultaneously and to examine their expression ratio in total RNA extracted from frozen liver tissues of 37 patients with hepatocellular carcinoma, five patients with hepatoblastoma, and 15 non-neoplastic liver tissues.
RESULTS: The ratio of HNF-1 to vHNF-1 mRNA was higher in well-differentiated cases than in poorly-differentiated and undifferentiated cases, except that one poorly-differentiated hepatoblastoma displayed a high ratio. Non-neoplastic liver tissues had low ratios similar to poorly-differentiated hepatocellular carcinoma, the reason for which remained unknown. However, chronic hepatitis and liver cirrhosis cases also demonstrated low ratios, and hence degenerative changes themselves displayed no obvious influence on such ratios. Thus, the gene expression of HNF-1 and vHNF-1 seemed to be differentially regulated in neoplastic and non-neoplastic hepatocytes.
CONCLUSIONS: These results suggested that the ratio of HNF-1 to vHNF-1 mRNA correlated with histological differentiation of HCC and hepatoblastoma.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8912143     DOI: 10.1016/s0168-8278(96)80203-0

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  6 in total

1.  Replication advantage and host factor-independent phenotypes attributable to a common naturally occurring capsid mutation (I97L) in human hepatitis B virus.

Authors:  Fat-Moon Suk; Min-Hui Lin; Margaret Newman; Shann Pan; Sheng-Hsuan Chen; Jean-Dean Liu; Chiaho Shih
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

Review 2.  Liver enriched transcription factors and differentiation of hepatocellular carcinoma.

Authors:  Y Hayashi; W Wang; T Ninomiya; H Nagano; K Ohta; H Itoh
Journal:  Mol Pathol       Date:  1999-02

3.  Expression of bile duct transcription factor HNF1β predicts early tumor recurrence and is a stage-independent prognostic factor in hepatocellular carcinoma.

Authors:  Ray-Hwang Yuan; Hong-Shiee Lai; Hey-Chi Hsu; Po-Lin Lai; Yung-Ming Jeng
Journal:  J Gastrointest Surg       Date:  2014-07-23       Impact factor: 3.452

4.  Overexpression Of Hepatocyte Nuclear Factor-1beta Predicting Poor Prognosis Is Associated With Biliary Phenotype In Patients With Hepatocellular Carcinoma.

Authors:  Dan-Dan Yu; Ying-Ying Jing; Shi-Wei Guo; Fei Ye; Wen Lu; Quan Li; Yu-Long Dong; Lu Gao; Yu-Ting Yang; Yang Yang; Meng-Chao Wu; Li-Xin Wei
Journal:  Sci Rep       Date:  2015-08-27       Impact factor: 4.379

Review 5.  A review on hepatocyte nuclear factor-1beta and tumor.

Authors:  Dan-Dan Yu; Shi-Wei Guo; Ying-Ying Jing; Yu-Long Dong; Li-Xin Wei
Journal:  Cell Biosci       Date:  2015-10-13       Impact factor: 7.133

Review 6.  Hepatocyte nuclear factor 1 beta: A perspective in cancer.

Authors:  Shubhra Chandra; Srilakshmi Srinivasan; Jyotsna Batra
Journal:  Cancer Med       Date:  2021-02-13       Impact factor: 4.452

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.